tradingkey.logo

Neurogene Inc <NGNE.OQ> expected to post a loss of $1.06 a share - Earnings Preview

ReutersMay 6, 2025 1:38 PM
  • Neurogene Inc NGNE.OQ NGNE.O is expected to show no change in quarterly revenue when it reports results on May 8 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Neurogene Inc is for a loss of $1.06 per share.

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Neurogene Inc is $46.00​, above​ its last closing price of $15.11. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-1.13

-0.99

Beat

12.4

Sep. 30 2024

-1.22

-1.22

-1.19

Beat

2.6

Jun. 30 2024

-1.04

-1.05

-1.09

Missed

-3.8​

Mar. 31 2024

-1.12

-1.13

-1.00

Beat

11.9

​​Dec. 31 2023

-1.17

-1.17

-1.51

Missed

-28.7

-1.64

-0.80

Mar. 31 2023

-2.51

-2.50

-5.12

Missed

-104.8

This summary was machine generated May 6 at 13:38 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI